Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells

Journal of Experimental Therapeutics and Oncology

Volumn 2, Issue 4, 2002, Pages 213-218

  Berkovic, Dinko ^a   Berkovic, Katharina ^a   Binder, Claudia ^a   Haase, Detlef ^a   Fleer, Eduard A M ^a  

^a KLINIKEN MARIA HILF GMBH   (Germany)

Author keywords

Alkylphosphocholines; Etherlipid analogues; Hexadecylphosphocholine; Phospholipase D; Phospholipid metabolism; Sphingomyelinase

Indexed keywords

MEMBRANE LIPID; MILTEFOSINE; PHOSPHOLIPASE; PHOSPHOLIPASE D; PHOSPHORYLCHOLINE DERIVATIVE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; CELL DIVISION; DRUG EFFECT; ENZYMOLOGY; LEUKEMIA; METABOLISM;

CELL DIVISION; HUMANS; LEUKEMIA; PHOSPHOLIPASE D; PHOSPHORYLCHOLINE; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036638615     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1359-4117.2002.01036.x     Document Type: Article

References (35)

1. Etherlipid derivatives: Antineoplastic activities in vitro and structure-relationship
2. Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells
3. Characterization of the antitumor activity of hexadecylphosphocholine
4. Hexadecylphosphocholine in the treatment of skin metastases in breast cancer patients
5. Phase II trial of orally administered miltefosine in advanced colorectal cancer
6. Daily oral miltefosine (hexadecylphosphocholine) in patients with advanced non small cell lung cancer. A phase II study
7. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas
8. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in leukemic cells
9. The antineoplastic activity of hexadecylphosphocholine is associated with tumor cell differentiation
10. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells
11. Antiinvasive activity of hexadecylphosphocholine in vitro
12. Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2
13. Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF mRNA in human mononuclear cells
14. Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues
15. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells
16. Hexadecylphosphocholine inhibits translocation of CTP: Cholinephosphate-cytidylyltranferase in Madin-Darby canine kidney cells
17. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL 60 cells
18. Inhibition of protein kinase C (sodium plus potassium) activated adenosine triphosphatase and sodium pump by synthetic phospholipid analogues
19. Inhibition of growth factor dependent inositiol phosphate Ca2+ signalling by antitumor ether lipid analogues
20. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity
21. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues
22. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine specific phospholipase C in human leukemia cells
23. 2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine
24. Alkyllysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis
25. A simplification of the protein assay method of Lowry et al. which is more generally applicable
26. Tumor necrosis factor induces rapid production of 1,2 diacylglycerol by a phosphatidylcholine-specific phospholipase C
27. TNF activates NFκB by phosphatidylcholinespecific phospholipase C-induced acidic sphingomyelin breakdown
28. Regulation of phospholipase D in HL60 cells
29. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues
30. Inhibition of cellular transport systems by alkyl phospholipid analogues in HL60 human leukemic cells
31. The antitumor phospholipid analogue hexadecylphosphocholine activates cellular phospholipase D
32. Synthetic phospholipids as substrates for phospholipase C from bacillus cereus
33. Alkylphosphate esters as inhibitors of phospholipase D
34. Hexadecylphosphocholine and 2-modified 1,3-diacylglycerols as effectors of phospholipase D
35. 3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor or interleukin 1 alpha